Yanhong Bu

496 total citations
26 papers, 377 citations indexed

About

Yanhong Bu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yanhong Bu has authored 26 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Yanhong Bu's work include Sphingolipid Metabolism and Signaling (9 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Immune Cell Function and Interaction (3 papers). Yanhong Bu is often cited by papers focused on Sphingolipid Metabolism and Signaling (9 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Immune Cell Function and Interaction (3 papers). Yanhong Bu collaborates with scholars based in China and Saint Kitts and Nevis. Yanhong Bu's co-authors include Hong Wu, Ran Deng, Yan Wang, Yan Wang, Ronghui Wang, Yongjun Wang, Yao Yao, Ningjie Zhang, Liyao Fu and Mengdie Wang and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and Bone.

In The Last Decade

Yanhong Bu

25 papers receiving 374 citations

Peers

Yanhong Bu
Qi Zhu China
Yan Long China
Mao Lin China
Sally A. Nicholas United Kingdom
Yanhong Bu
Citations per year, relative to Yanhong Bu Yanhong Bu (= 1×) peers Nicole Hannemann

Countries citing papers authored by Yanhong Bu

Since Specialization
Citations

This map shows the geographic impact of Yanhong Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhong Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhong Bu more than expected).

Fields of papers citing papers by Yanhong Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhong Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhong Bu. The network helps show where Yanhong Bu may publish in the future.

Co-authorship network of co-authors of Yanhong Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhong Bu. A scholar is included among the top collaborators of Yanhong Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhong Bu. Yanhong Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bu, Yanhong, et al.. (2025). Geniposide Improves Glycolysis Driven Angiogenesis in Experimentary Arthritis by Inhibiting SphK1PI3K ‐Akt‐ PFKFB3 Signal. Phytotherapy Research. 39(8). 3419–3431. 1 indexed citations
2.
Bu, Yanhong, et al.. (2025). Rare case of tacrolimus-induced immune hemolytic anemia in a child after liver transplantation. Transfusion and Apheresis Science. 64(4). 104172–104172. 1 indexed citations
4.
Han, Yuxin, et al.. (2024). Adipose Tissue Plasticity: A Comprehensive Definition and Multidimensional Insight. Biomolecules. 14(10). 1223–1223. 9 indexed citations
5.
Deng, Ran, et al.. (2023). Geniposide augments apoptosis in fibroblast-like synoviocytes by restoring hypoxia-enhanced JNK-BNIP3-mediated autophagy. Inflammation Research. 72(8). 1745–1760. 5 indexed citations
7.
Bu, Yanhong, Hong Wu, Ran Deng, & Yan Wang. (2022). The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN. Inflammopharmacology. 30(3). 1047–1062. 17 indexed citations
9.
Bu, Yanhong, Hong Wu, Ran Deng, & Yan Wang. (2022). Geniposide restricts angiogenesis in experimentary arthritis via inhibiting Dnmt1-mediated PTEN hypermethylation. International Immunopharmacology. 111. 109087–109087. 7 indexed citations
10.
Bu, Yanhong, Hong Wu, Ran Deng, & Yan Wang. (2021). Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Frontiers in Pharmacology. 12. 733387–733387. 44 indexed citations
12.
13.
14.
Zhang, Ningjie, Liyao Fu, Yanhong Bu, Yao Yao, & Yongjun Wang. (2017). Downregulated expression of miR-223 promotes Toll-like receptor-activated inflammatory responses in macrophages by targeting RhoB. Molecular Immunology. 91. 42–48. 40 indexed citations
15.
Tian, Lili, et al.. (2016). Dental caries and risk indicators for patients with leprosy in China. International Dental Journal. 67(1). 59–64. 3 indexed citations
16.
Chen, En, et al.. (2016). Allele polymorphism and haplotype diversity of MICA/B in Tujia nationality of Zhangjiajie, Hunan Province, China. Human Immunology. 77(5). 411–417. 5 indexed citations
17.
Chen, En, et al.. (2016). MICA/B genotyping of Tujias from Zhangjiajie, Hunan Province, China. Human Immunology. 77(4). 340–341. 3 indexed citations
18.
Bu, Yanhong, Yuling He, Hou‐De Zhou, et al.. (2010). Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. Journal of Endocrinology. 206(3). 271–277. 23 indexed citations
19.
Bu, Yanhong, et al.. (2009). Insulin receptor substrate 2 plays important roles in 17β-estradiol-induced bone formation. Journal of Endocrinological Investigation. 32(8). 682–689. 3 indexed citations
20.
Zhou, Hou‐De, Yanhong Bu, Yiqun Peng, et al.. (2007). Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation. Journal of Molecular Medicine. 85(9). 985–996. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026